The stromal derived factor-1\CXCR4 axis – a legitimate therapeutic target in multiple myeloma?
Katz, Ben-Zion, Tavor, SigalVolume:
50
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428190902991837
Date:
January, 2009
File:
PDF, 138 KB
english, 2009